Relevance,RGD ID,Symbol,Name,LOD,P Value,Trait,Sub Trait,Chr,Start,Stop,Species,Annotations,Match,Type 1000,8655655,Arrd2,Age-related retinal degeneration QTL 2,7.79,,retinal layer morphology trait (VT:0003727),percentage of study population developing retinopathy during a period of time (CMO:0002453),1,183970203,243914901,Rat,n/a,region,qtl 1000,8655855,Arrd3,Age-related retinal degeneration QTL 3,3.07,,lens clarity trait (VT:0001304),cataract incidence/prevalence measurement (CMO:0001585),1,183970203,243914901,Rat,n/a,region,qtl 1000,2293700,Bmd27,Bone mineral density QTL 27,6.6,0.0001,femur mineral mass (VT:0010011),trabecular volumetric bone mineral density (CMO:0001729),1,224054293,243747962,Rat,n/a,region,qtl 1000,2293701,Bmd34,Bone mineral density QTL 34,8.3,0.0001,femur strength trait (VT:0010010),femoral neck ultimate force (CMO:0001703),1,224054293,243747962,Rat,n/a,region,qtl 1000,2300175,Bmd40,Bone mineral density QTL 40,15.4,0.0001,femur mineral mass (VT:0010011),bone mineral density (CMO:0001226),1,201554356,246554356,Rat,n/a,region,qtl 1000,1300168,Bp170,Blood pressure QTL 170,2.76,,arterial blood pressure trait (VT:2000000),mean arterial blood pressure (CMO:0000009),1,207702246,228581766,Rat,n/a,region,qtl 1000,1358898,Bp255,Blood pressure QTL 255,3.6,,arterial blood pressure trait (VT:2000000),mean arterial blood pressure (CMO:0000009),1,191019702,246062233,Rat,n/a,region,qtl 1000,1358890,Bp259,Blood pressure QTL 259,3.06,,arterial blood pressure trait (VT:2000000),mean arterial blood pressure (CMO:0000009),1,210702053,260522016,Rat,n/a,region,qtl 1000,2292220,Bp306,Blood pressure QTL 306,3.47,0.00087,arterial blood pressure trait (VT:2000000),systolic blood pressure (CMO:0000004),1,164310393,243914901,Rat,n/a,region,qtl 1000,7421630,Bp362,Blood pressure QTL 362,,0.001,arterial blood pressure trait (VT:2000000),mean arterial blood pressure (CMO:0000009),1,118608292,241799120,Rat,n/a,region,qtl 1000,61376,Bp42,Blood pressure QTL 42,23.4,,arterial blood pressure trait (VT:2000000),systolic blood pressure (CMO:0000004),1,197814409,242814409,Rat,n/a,region,qtl 1000,2293655,Bss36,Bone structure and strength QTL 36,10.66,0.0001,femur strength trait (VT:0010010),femur ultimate force (CMO:0001675),1,201554356,246554356,Rat,n/a,region,qtl 1000,2293694,Bss38,Bone structure and strength QTL 38,7.05,0.0001,femur strength trait (VT:0010010),femur stiffness (CMO:0001674),1,201554356,246554356,Rat,n/a,region,qtl 1000,2293674,Bss39,Bone structure and strength QTL 39,7.1,0.0001,femur strength trait (VT:0010010),femur total energy absorbed before break (CMO:0001677),1,201554356,246554356,Rat,n/a,region,qtl 1000,631843,Bw116,Body weight QTL 116,4.1,0.016,abdominal adipose amount (VT:1000220),abdominal fat pad weight (CMO:0000088),1,224054293,260122809,Rat,n/a,region,qtl 1000,1600392,Bw123,Body weight QTL 123,,0.001,body mass (VT:0001259),body weight (CMO:0000012),1,223201027,260522016,Rat,n/a,region,qtl 1000,10059587,Bw173,Body weight QTL 173,3.23,0.025,body mass (VT:0001259),body weight (CMO:0000012),1,202069611,247069611,Rat,n/a,region,qtl 1000,1354661,Bw33,Body weight QTL 33,5.2,,body mass (VT:0001259),body weight (CMO:0000012),1,151162512,256448636,Rat,n/a,region,qtl 1000,1354610,Bw34,Body weight QTL 34,4.1,,body mass (VT:0001259),body weight (CMO:0000012),1,151162512,256448636,Rat,n/a,region,qtl 1000,1357335,Bw39,Body weight QTL 39,3.3,,body mass (VT:0001259),body weight (CMO:0000012),1,197814409,242814409,Rat,n/a,region,qtl 1000,1357404,Bw42,Body weight QTL 42,4.49,0.0001,body mass (VT:0001259),body weight (CMO:0000012),1,206329708,251329708,Rat,n/a,region,qtl 1000,1357399,Bw45,Body weight QTL 45,3.05,,body mass (VT:0001259),body mass index (BMI) (CMO:0000105),1,206329708,251329708,Rat,n/a,region,qtl 1000,1549910,Bw54,Body weight QTL 54,,0.05,body mass (VT:0001259),body weight (CMO:0000012),1,214647894,259647894,Rat,n/a,region,qtl 1000,2292216,Bw80,Body weight QTL 80,3.23,0.0019,body mass (VT:0001259),body weight (CMO:0000012),1,213533809,243914901,Rat,n/a,region,qtl 1000,2302375,Bw83,Body weight QTL 83,4.87,0.0002,body mass (VT:0001259),body weight (CMO:0000012),1,197697768,242697768,Rat,n/a,region,qtl 1000,6480786,Bw97,Body weight QTL 97,5.03,,body mass (VT:0001259),body weight (CMO:0000012),1,225126575,227604520,Rat,n/a,region,qtl 1000,1354624,Cm35,Cardiac mass QTL35,5.7,,heart left ventricle mass (VT:0007031),calculated heart weight (CMO:0000073),1,177227632,256448636,Rat,n/a,region,qtl 1000,1358292,Cm37,Cardiac mass QTL 37,6.2,0.00000081,heart mass (VT:0007028),heart weight to body weight ratio (CMO:0000074),1,196248093,241248093,Rat,n/a,region,qtl 1000,631658,Cm7,Cardiac mass QTL 7,5.32,0.0001,aorta mass (VT:0002845),aorta weight (CMO:0000076),1,196248093,241248093,Rat,n/a,region,qtl 1000,61327,Eae7,Experimental allergic encephalomyelitis QTL 7,5.6,,body mass (VT:0001259),change in body weight (CMO:0002045),1,216255568,260522016,Rat,n/a,region,qtl 1000,1600397,Edcs4,Endometrial carcinoma susceptibility QTL 4,2.2,,uterus morphology trait (VT:0001120),percentage of study population developing endometrioid carcinoma during a period of time (CMO:0001759),1,206081677,251081677,Rat,n/a,region,qtl 1000,8552891,Epfw5,Epididymal fat weight QTL 5,4.4,,epididymal fat pad mass (VT:0010421),epididymal fat pad weight to body weight ratio (CMO:0000658),1,193113876,238113876,Rat,n/a,region,qtl 1000,1358191,Ept10,Estrogen-induced pituitary tumorigenesis QTL 10,3.8,,pituitary gland mass (VT:0010496),pituitary gland wet weight (CMO:0000853),1,192825253,243914732,Rat,n/a,region,qtl 1000,2312564,Glom18,Glomerulus QTL 18,2.4,0.003,kidney glomerulus morphology trait (VT:0005325),index of glomerular damage (CMO:0001135),1,185356336,231689108,Rat,n/a,region,qtl 1000,724552,Glom2,Glomerulus QTL 2,3.3,0.0001,kidney glomerulus morphology trait (VT:0005325),count of superficial glomeruli directly contacting the kidney surface (CMO:0001001),1,222363780,260522016,Rat,n/a,region,qtl 1000,634321,Hc1,Hypercalciuria QTL 1,2.91,,urine calcium amount (VT:0002985),urine calcium excretion rate (CMO:0000763),1,178810256,240830002,Rat,n/a,region,qtl 1000,1600363,Hc6,Hypercalciuria QTL 6,2.7,,urine calcium amount (VT:0002985),urine calcium excretion rate (CMO:0000763),1,203995416,244113296,Rat,n/a,region,qtl 1000,1549837,Hcar15,Hepatocarcinoma resistance QTL 15,,0.05,liver integrity trait (VT:0010547),liver tumorous lesion number (CMO:0001068),1,153136852,260522016,Rat,n/a,region,qtl 1000,634340,Hcar5,Hepatocarcinoma resistance QTL 5,8,,liver integrity trait (VT:0010547),liver tumorous lesion number (CMO:0001068),1,214537555,226660468,Rat,n/a,region,qtl 1000,738032,Hcas5,Hepatocarcinoma susceptibility QTL 5,3.12,,liver integrity trait (VT:0010547),liver tumorous lesion number (CMO:0001068),1,176426412,257976495,Rat,n/a,region,qtl 1000,2302378,Insul11,Insulin level QTL 11,3.25,,blood insulin amount (VT:0001560),serum insulin level (CMO:0000358),1,144267353,251128347,Rat,n/a,region,qtl 1000,724538,Kidm1,Kidney mass QTL 1,3.2,,kidney mass (VT:0002707),calculated kidney weight (CMO:0000160),1,213707201,252085212,Rat,n/a,region,qtl 1000,1354646,Kidm18,Kidney mass QTL 18,5.7,,kidney mass (VT:0002707),calculated kidney weight (CMO:0000160),1,151162512,256448636,Rat,n/a,region,qtl 1000,1354652,Kidm20,Kidney mass QTL 20,4.3,,kidney mass (VT:0002707),calculated kidney weight (CMO:0000160),1,177227632,256448636,Rat,n/a,region,qtl 1000,1358916,Kidm22,Kidney mass QTL 22,3.32,,kidney mass (VT:0002707),both kidneys wet weight to body weight ratio (CMO:0000340),1,210702053,240947965,Rat,n/a,region,qtl 1000,1578763,Kidm29,Kidney mass QTL 29,3.3,0.0001,kidney mass (VT:0002707),both kidneys wet weight (CMO:0000085),1,179567751,260522016,Rat,n/a,region,qtl 1000,10059590,Kidm44,Kidney mass QTL 44,3.42,0.025,kidney mass (VT:0002707),both kidneys wet weight to body weight ratio (CMO:0000340),1,191033875,236033875,Rat,n/a,region,qtl 1000,1600374,Mcs17,Mammary carcinoma susceptibility QTL 17,3,,mammary gland integrity trait (VT:0010552),mammary tumor number (CMO:0000343),1,197670404,242670404,Rat,n/a,region,qtl 1000,7794788,Mcs32,Mammary carcinoma susceptibility QTL 32,2.61,,mammary gland integrity trait (VT:0010552),mammary tumor incidence/prevalence measurement (CMO:0000946),1,115540693,238914717,Rat,n/a,region,qtl 1000,61400,Niddm1,Non-insulin dependent diabetes mellitus QTL 1,11,,blood glucose amount (VT:0000188),blood glucose level (CMO:0000046),1,218753689,245907899,Rat,n/a,region,qtl 1000,70211,Niddm24,Non-insulin dependent diabetes mellitus QTL 24,3.79,,blood glucose amount (VT:0000188),blood glucose level area under curve (AUC) (CMO:0000350),1,214647894,259647894,Rat,n/a,region,qtl 1000,631838,Niddm36,Non-insulin dependent diabetes mellitus QTL 36,,0.01,insulin secretion trait (VT:0003564),calculated pancreatic islet insulin release measurement (CMO:0001217),1,184550676,229550676,Rat,n/a,region,qtl 1000,634313,Niddm43,Non-insulin dependent diabetes mellitus QTL 43,,,blood glucose amount (VT:0000188),blood glucose level (CMO:0000046),1,199050459,259647894,Rat,n/a,region,qtl 1000,734767,Niddm57,Non-insulin dependent diabetes mellitus QTL 57,,,body mass (VT:0001259),body weight (CMO:0000012),1,224054293,260122809,Rat,n/a,region,qtl 1000,734769,Niddm58,Non-insulin dependent diabetes mellitus QTL 58,,,body mass (VT:0001259),body weight (CMO:0000012),1,224569538,260122809,Rat,n/a,region,qtl 1000,734768,Niddm59,Non-insulin dependent diabetes mellitus QTL 59,,,body mass (VT:0001259),body weight (CMO:0000012),1,213843987,258843987,Rat,n/a,region,qtl 1000,1600388,Niddm67,Non-insulin dependent diabetes mellitus QTL 67,5.84,0.000004,blood glucose amount (VT:0000188),blood glucose level area under curve (AUC) (CMO:0000350),1,195804352,257091168,Rat,n/a,region,qtl 1000,1600396,Niddm68,Non-insulin dependent diabetes mellitus QTL 68,4.97,0.0003,blood glucose amount (VT:0000188),blood glucose level area under curve (AUC) (CMO:0000350),1,195804352,257091168,Rat,n/a,region,qtl 1000,1600395,Niddm69,Non-insulin dependent diabetes mellitus QTL 69,4.14,0.0002,blood insulin amount (VT:0001560),plasma insulin level (CMO:0000342),1,195804352,257091168,Rat,n/a,region,qtl 1000,61455,Niddm7,Non-insulin dependent diabetes mellitus QTL 7,5.5,,blood glucose amount (VT:0000188),plasma glucose level (CMO:0000042),1,214537555,238757011,Rat,n/a,region,qtl 1000,2302040,Pia35,Pristane induced arthritis QTL 35,3.8,0.001,blood immunoglobulin amount (VT:0002460),serum immunoglobulin G1 level (CMO:0002115),1,216255568,260522016,Rat,n/a,region,qtl 1000,1578778,Pur4,Proteinuria QTL 4,3.3,0.003,total urine protein amount (VT:0000032),urine total protein excretion rate (CMO:0000756),1,150700247,252085048,Rat,n/a,region,qtl 1000,724533,Rf51,Renal function QTL 51,5.3,0.0002,kidney plasma flow trait (VT:0005524),renal plasma flow (CMO:0001914),1,218753816,256448513,Rat,n/a,region,qtl 1000,1598821,Rf55,Renal function QTL 55,6.3,,renal blood flow trait (VT:2000006),ratio of change in renal blood flow to change in renal perfusion pressure (CMO:0001239),1,218748008,257976495,Rat,n/a,region,qtl 1000,1354580,Scort1,Serum corticosterone level QTL 1,3.4,,blood corticosterone amount (VT:0005345),blood corticosterone level (CMO:0001172),1,156677124,256448636,Rat,n/a,region,qtl 1000,10053715,Scort24,Serum corticosterone level QTL 24,2.13,0.0088,blood corticosterone amount (VT:0005345),plasma corticosterone level (CMO:0001173),1,221414816,260522016,Rat,n/a,region,qtl 1000,631215,Stl8,Serum triglyceride level QTL 8,9.27,0.0001,blood triglyceride amount (VT:0002644),serum triglyceride level (CMO:0000360),1,225126575,260522016,Rat,n/a,region,qtl 1000,1641926,Teswt2,Testicular weight QTL 2,2.82,,testis mass (VT:1000644),both testes wet weight (CMO:0000175),1,197697768,238755659,Rat,n/a,region,qtl 1000,1298084,Thym4,Thymus enlargement QTL 4,10.68,,thymus mass (VT:0004954),thymus weight to body weight ratio (CMO:0000612),1,197814409,242814409,Rat,n/a,region,qtl 1000,731175,Uae20,Urinary albumin excretion QTL 20,3.5,0.0018,urine albumin amount (VT:0002871),urine albumin excretion rate (CMO:0000757),1,221264111,259647894,Rat,n/a,region,qtl 1000,1578759,Uae30,Urinary albumin excretion QTL 30,3.3,0.003,urine albumin amount (VT:0002871),urine albumin excretion rate (CMO:0000757),1,150700247,252085048,Rat,n/a,region,qtl 1000,7394701,Uae46,Urinary albumin excretion QTL 46,3.6,0.0056,urine albumin amount (VT:0002871),urine albumin excretion rate (CMO:0000757),1,201554356,246554356,Rat,n/a,region,qtl 1000,724531,Uae5,Urinary albumin excretion QTL 5,4,,urine albumin amount (VT:0002871),urine albumin level (CMO:0000130),1,150700142,252085212,Rat,n/a,region,qtl